| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443667 | European Journal of Cancer | 2014 | 7 Pages |
Abstract
Overall survival was similar in this trial compared to first-line chemotherapy in this unselected patient population. Dose escalation to the development of grade 2 skin rash was associated with improved survival in this patient population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
J.R. Brahmer, J.W. Lee, A.M. Traynor, M.M. Hidalgo, J.M. Kolesar, J.M. Siegfried, P.P. Guaglianone, J.D. Patel, M.D. Keppen, J.H. Schiller,